NCT00678743View on ClinicalTrials.gov

An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
Dyslipidemias
Interventions
DRUG

Omacor + simvastatin

Omacor 4 grams/day plus simvastatin 80 mg/day. Simvastatin dose adjusted at Investigator discretion after week 6.

All Listed Sponsors
collaborator

Reliant Pharmaceuticals

INDUSTRY

lead

Provident Clinical Research

OTHER

NCT00678743 - An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin | Biotech Hunter | Biotech Hunter